Category: I.T.

Growth of the IoT market in the US

Internet of Things (IoT) is a system consisting of interconnected computing devices, machines etc.which have unique identifiers and can pass information or data over a network without needing human-to-human or computer-to-human communication. As per the “US Internet of Things (IoT) Market by Component, By Communication Technology, By End Use Industry, Competition Forecast & Opportunities, 2012 – 2022”, the market of IoT in the US is expected to increase at a CAGR of more than 14% over a span of

RF developer and cybersecurity firm granted R&D grant for IoT devices

The partnership is developing the MEDIcal CYbersecure NEtwork project (“MEDICYNE”) project for an end-to-end secure communications answer for medical IoT devices. As the use of IoT-based, connected healthcare objects and devices has up, issues concerning their vulnerability to cyberattacks have conjointly exaggerated. samples of potential security problems embody the hijacking of management of patients’ connected

Amazon develops a longer-range wireless network for IoT devices opposition is developing a longer-range comparable to Bluetooth and WiFi wireless protocols that the biggest U.S. on-line merchandiser hopes third parties can eventually use in sensible devices. The Amazon Sidewalk proclaimed aboard a brand new vary of Echo speakers and a polyglot mode for its Alexa virtual assistant, underscores the firm’s growth expectations for

Smartiply Edge Gateway Gets Added to AWS Partner Device Catalog

Smartiply brings to the globe an Edge-to-Cloud hybrid platform, leverage Amazon Web Services (AWS), that are designed to optimize computing resources and drive the native higher cognitive processes, the more reducing total value of possession for AWS web of Things (IoT) applications. The Smartiply platform permits AWS Lambda functions and machine learning models to run

Guerbet and IBM Watson Health announced a second co-development project for leveraging artificial intelligence in medical imaging

Guerbet, a world specialist in distinction agents and solutions for diagnostic and interventional medical imaging, these days proclaimed that it’s signed a brand new agreement with IBM Watson Health to co-develop and co-commercialize a man-made intelligence (AI) answer to assist clinicians to diagnose and monitor patients with prostate cancer. Under this second program, Guerbet and